Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 885 entries
View as:

A Study of JNJ-64300535 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04736147 Org: User:
Start: 02/03/21 End: 12/07/21 Due: 12/07/22

A Study of Switching to RPV Plus Other ARVs in HIV-1-infected Children (Aged 2 to <12 Years) Who Are Virologically Suppressed

Phase: N/A Priority: Normal
NCT ID: NCT04012931 Org: User:
Start: 07/18/19 End: 02/23/23 Due: 02/23/24

Concerta (Methylphenidate) -To-Generic Switch Study

Phase: N/A Priority: Normal
NCT ID: NCT02730572 Org: User:
Start: 09/30/15 End: 10/31/16 Due: 10/31/17

A Study to Investigate the Effect of JNJ-42847922 on Polysomnography Measures in Patients With Major Depressive Disorder With Insomnia Who Are Stably Treated With Antidepressants

Phase: N/A Priority: Normal
NCT ID: NCT02067299 Org: User:
Start: 02/28/14 End: 12/31/14 Due: 12/31/15

A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT03662542 Org: User:
Start: 11/20/18 End: 11/15/21 Due: 11/15/22

A Study Evaluating the Effects of Siltuximab on the Heart in Patients With Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Indolent Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01219010 Org: User:
Start: 10/31/10 End: 03/31/14 Due: 03/31/15

A Bioequivalence Study of Norgestimate /Ethinyl Estradiol (NGM/EE) Tablets Manufactured at 2 Different Facilities

Phase: N/A Priority: Normal
NCT ID: NCT02127593 Org: User:
Start: 06/30/13 End: 09/30/14 Due: 09/30/15

Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants

Phase: N/A Priority: Normal
NCT ID: NCT02087579 Org: User:
Start: 02/28/14 End: 12/31/14 Due: 12/31/15

A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Severely Obese Participants With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT03586830 Org: User:
Start: 06/26/18 End: 04/05/19 Due: 04/05/20

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of JNJ-54861911 in Healthy Volunteers Compared With Placebo

Phase: N/A Priority: Normal
NCT ID: NCT01827982 Org: User:
Start: 03/31/13 End: 07/31/13 Due: 07/31/14

A Study of Four Different Oral Tablet Formulations of Lazertinib (JNJ-73841937) in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT05742594 Org: User:
Start: 01/03/23 End: 04/03/23 Due: 04/03/24

A Study of Itraconazole in the Management of Superficial Fungal Infections in India

Phase: N/A Priority: Normal
NCT ID: NCT03923010 Org: User:
Start: 08/06/19 End: 03/27/20 Due: 03/27/21

A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone Acetate in Male Participants With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00924469 Org: User:
Start: 11/30/09 End: 03/31/12 Due: 03/31/13

A Study to Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass Spectrometry

Phase: N/A Priority: Normal
NCT ID: NCT02462473 Org: User:
Start: 05/31/15 End: 01/31/16 Due: 01/31/17

A Study of Bermekimab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa

Phase: N/A Priority: Normal
NCT ID: NCT04988308 Org: User:
Start: 10/12/21 End: 11/23/22 Due: 11/23/23

A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT01780259 Org: User:
Start: 12/31/12 End: 05/31/13 Due: 05/31/14

A Study of Rilematovir in Infants and Children and Subsequently in Neonates Hospitalized With Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus (RSV)

Phase: N/A Priority: Normal
NCT ID: NCT04583280 Org: User:
Start: 09/06/21 End: 03/18/22 Due: 03/18/23

Open-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia.

Phase: N/A Priority: Normal
NCT ID: NCT00488319 Org: User:
Start: 06/30/07 End: 07/31/12 Due: 07/31/13

A Study to Evaluate the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Moderate to Severe Plaque-type Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT03090100 Org: User:
Start: 04/27/17 End: 09/20/18 Due: 09/20/19

A Non-drug Study Profiling Cutaneous Lupus

Phase: N/A Priority: Normal
NCT ID: NCT01923415 Org: User:
Start: 04/30/13 End: 08/31/14 Due: 08/31/15

A Study of the Effects of Canagliflozin on Plasma Volume in Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01483781 Org: User:
Start: 12/31/11 End: 08/31/12 Due: 08/31/13

Pre-Approval Access Program for Talquetamab in Relapsed or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT05757973 Org: User:
Start: - End: - Due: -

A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections

Phase: N/A Priority: Normal
NCT ID: NCT01110382 Org: User:
Start: 12/31/10 End: 09/30/13 Due: 09/30/14

Study to Assess the Treatment Patterns in Metastatic Castration-Resistance Prostate Cancer (mCRPC)

Phase: N/A Priority: Normal
NCT ID: NCT02230059 Org: User:
Start: 07/31/13 End: 05/31/14 Due: 05/31/15

A Study to Assess the Effects of Age and Gender on the Pharmacokinetics of JNJ-42847922 in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT02837692 Org: User:
Start: 06/08/16 End: 09/11/17 Due: 09/11/18